229
Participants
Start Date
February 9, 2016
Primary Completion Date
June 18, 2019
Study Completion Date
November 26, 2020
Luspatercept
Placebo
UZ Brussels, Brussels
Spaarne Ziekenhuis, Hoofddorp
Algemeen Ziekenhuis Klina, Brasschaat
UZ Leuven, Leuven
Cliniques Universitaires UCL de Mont-Godine, Yvoir
Grand Hopital de Charleroi, Charleroi
AZ Sint-Jan AV Brugge, Bruges
UZ Gent, Ghent
Columbia-Presbyterian Medical Center, New York
Montefiore Medical Center Albert Einstein Cancer Center, The Bronx
Institut Paoli Calmettes, Marseille
Azienda Ospedaliera Santi Antonio Biagio E Cesare Arrigo, Allessandria
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Fondazione IRCCS Policlinico San Matteo, Pavia
Hospital General Universitario Gregorio Marañon, Madrid
Emory University Hospital, Atlanta
Medizinische Hochschule Hannover, Hanover
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse
Hospital Universitario Central de Asturias, Oviedo
Hopital Haut Leveque, Pessac
H Lee Moffitt Cancer Center and Research Institute, Tampa
Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul
Ege Universitesi Tip Fakultesi Hastanesi, Izmir
Hospital Universitario de Salamanca, Salamanca
Hopital Bretonneau, Tours
Vanderbilt University Medical Center, Nashville
CHU Hotel, Grenoble
Azienda Ospedaliero Universitaria Di Bologna Policlinico Sorsola Malpighi, Bologna
Universitätsklinikum Düsseldorf, Düsseldorf
Marien Hospital, Düsseldorf
Hospital Universitario Virgen del Rocio, Seville
Gabrail Cancer Center, Canton
Hospital Universitario La Fe, Valencia
Karmanos Cancer Institute, Detroit
Hospital Universitario Cruces, Barakaldo
CHU d'Angers, Angers
Azienda Ospedaliera Universitaria Careggi, Florence
Universitatsklinikum Bonn, Bonn
CHRU de Lille-Hopital Claude Huriez Service des Maladies du Sang, Lille
Hopital civil, Strasbourg
Centre hospitalier Lyon Sud Hematologie, Pierre-Bénite
Ochsner Medical Institutions, New Orleans
Azienda Sanitaria Locale Lecce, Lecce
Hopital Saint Louis, Paris
Akademiska Sjukhuset, Uppsala
MD Anderson Cancer Center, Houston
Klinikum rechts der Isar der Technischen Universität München, München
Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria
Stanford Cancer Center, Stanford
Yale University School of Medicine, New Haven
Cleveland Clinic Taussig Cancer Institute, Cleveland
Tom Baker Cancer Center, Calgary
Juravinski Cancer Centre, Hamilton
Sunnybrook Health Sciences Centre, Toronto
Princess Margaret Hospital, Toronto
CHU de Nice Archet I, Nice
Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden
Fondazione Policlinico Universitario A Gemelli, Roma
Fondazione PTV Policlinico Tor Vergata, Roma
VU Medisch Centrum, Amsterdam
Universitair Medisch Centrum Groningen, Groningen
Hospital Universitario Vall D hebron, Barcelona
Instituto Catalan de Oncologia-Hospital Duran i Reynals, Barcelona
Sahlgrenska Universitetssjukhus, Gothenburg
Skanes Universitetssjukhus Lund, Lund
Karolinska University Hospital, Stockholm
Cukurova University Medical Faculty Balcali Hospital, Adana
Ankara University Medical Faculty Cebeci Hospital, Ankara
Aberdeen Royal Infirmary, Aberdeen
John Radcliffe Hospital, Headington
St James University Hospital, Leeds
Guys Hospital, London
Kings College Hospital, London
Kings Mill Hospital, Sutton in Ashfield
Lead Sponsor
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
INDUSTRY
Celgene
INDUSTRY